ELOX — Eloxx Pharmaceuticals Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro Cap

Annual balance sheet for Eloxx Pharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	42.3	19.2	1.13	0.111	4.79
Net Total Accounts Receivable
Net Total Receivables	—	—	—	2.72	0
Prepaid Expenses
Total Other Current Assets
Total Current Assets	43.5	20.1	1.55	2.98	5.27
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	1.66	0.994	0.164	0	0
Other Long Term Assets
Total Assets	45.1	21.1	1.71	2.98	5.27
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	9.96	23.1	22.7	27.3	17.2
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	22.8	31.8	24.3	27.3	17.2
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Total Equity	22.4	-10.7	-22.6	-24.3	-11.9
Total Liabilities & Shareholders' Equity	45.1	21.1	1.71	2.98	5.27
Total Common Shares Outstanding